-
1
-
-
33751513942
-
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
-
Tonus C, Neupert G, Sellinger M. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J Gastroenterol 2006; 12: 7007-7011
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7007-7011
-
-
Tonus, C.1
Neupert, G.2
Sellinger, M.3
-
2
-
-
33750626736
-
Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal. neoplasia
-
Shastri YM, Naumann M, Oremek GM, Hanisch E, Rosch W, Mossner J, Caspary WF, Stein JM. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal. neoplasia. Int J Cancer 2006; 119: 2651-2656
-
(2006)
Int J Cancer
, vol.119
, pp. 2651-2656
-
-
Shastri, Y.M.1
Naumann, M.2
Oremek, G.M.3
Hanisch, E.4
Rosch, W.5
Mossner, J.6
Caspary, W.F.7
Stein, J.M.8
-
3
-
-
29744464361
-
Fecal pyruvate kinase (M2-PK): A new predictor for inflammation and severity of pouchitis
-
Walkowiak J, Banasiewicz T, Krokowicz P, Hansdorfer-Korzon R, Drews M, Herzig KH. Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005; 40: 1493-1494
-
(2005)
Scand J Gastroenterol
, vol.40
, pp. 1493-1494
-
-
Walkowiak, J.1
Banasiewicz, T.2
Krokowicz, P.3
Hansdorfer-Korzon, R.4
Drews, M.5
Herzig, K.H.6
-
4
-
-
0037629022
-
Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls
-
Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Anticancer Res 2003; 23:851-853
-
(2003)
Anticancer Res
, vol.23
, pp. 851-853
-
-
Hardt, P.D.1
Toepler, M.2
Ngoumou, B.3
Rupp, J.4
Kloer, H.U.5
-
5
-
-
4644265292
-
Faecal tumour M2 pyruvate kinase: A new, sensitive screening tool for colorectal. cancer
-
Hardt PD, Mazurek S, Toepler M, Schlierbach P, Bretzel RG, Eigenbrodt E, Kloer HU. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal. cancer. Br J Cancer 2004; 91:980-984
-
(2004)
Br J Cancer
, vol.91
, pp. 980-984
-
-
Hardt, P.D.1
Mazurek, S.2
Toepler, M.3
Schlierbach, P.4
Bretzel, R.G.5
Eigenbrodt, E.6
Kloer, H.U.7
-
6
-
-
4444281174
-
Faecal pyruvate kinase type M2 - a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study
-
Naumann M, Schaum B, Oremek GM, Hanisch E, Rosch W, Mossner J, Caspary WF, Stein J. Faecal pyruvate kinase type M2 - a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study. Dtsch Med Wochenschr 2004; 129:1806-1807
-
(2004)
Dtsch Med Wochenschr
, vol.129
, pp. 1806-1807
-
-
Naumann, M.1
Schaum, B.2
Oremek, G.M.3
Hanisch, E.4
Rosch, W.5
Mossner, J.6
Caspary, W.F.7
Stein, J.8
-
7
-
-
17444394338
-
Comparison of different stool tests for the detection of cancer of the colon
-
Vogel T, Driemel C, Hauser A, Hansmann A, Lange S, Jonas M, Moslein G. Comparison of different stool tests for the detection of cancer of the colon. Dtsch Med Wochenschr 2005; 130:872-877
-
(2005)
Dtsch Med Wochenschr
, vol.130
, pp. 872-877
-
-
Vogel, T.1
Driemel, C.2
Hauser, A.3
Hansmann, A.4
Lange, S.5
Jonas, M.6
Moslein, G.7
|